Construction of State-of-the-Art Flow Chemistry Facility Commences
Cleaner, safer, faster flow chemistry will eventually replace most traditional batch chemistry methods for Chemical manufacture. Credit: CSIRO
Construction has commenced on a new $8 million Centre for Industrial Flow Chemistry at the CSIRO’s Normanby Rd Clayton site.
The purpose-built, 410m2 state-of-the-art facility will provide local manufacturers access to CSIRO’s flow chemistry technology.
CSIRO is a world leader in flow chemistry, which offers a cleaner, faster, more efficient and cost effective way to make chemicals.
Incorporating all of CSIRO’s flow chemistry equipment, the centre’s capabilities will range from small-scale discovery tools to large-scale industrial reactors.
Services will include process research and development operations for industrial clients, technology transfer to commercial manufacture, in-house training for industrial collaborators and innovative research on new process technology for chemical manufacture.
Early adopter of flow chemistry, local businessman Zoran Manev, worked with CSIRO’s FloWorks team to integrate flow chemistry into his operations.
Mr Manev’s Noble Park chemical manufacturing plant, Boron Molecular, supplies fine chemicals to the Australian and international pharmaceutical and materials sector.
Mr Manev said flow chemistry enables his plant to make purer molecules with fewer side products and fewer issues when scaling up to manufacture from small scale to larger tonne lots.
“With flow we’re using far less solvents and energy and discarding far less waste material into the environment than we would otherwise,” he said.
Director of the new FloWorks Centre, Dr Christian Hornung, said the new facility will offer a unique, complete package to chemical manufacturers all the way through development - from early discovery stages to industrial scale-up and tech transfer.
“The new collaborative space will generate greater engagement with industry and other research bodies,” Dr Hornung said.
“I see flow technology eventually being taken up by chemical manufacturers in all areas,” he said.
Construction of the facility is being undertaken by Monaco and Hickey Pty Ltd and is due for completion by November 2018.
This article has been republished from materials provided by CSIRO. Note: material may have been edited for length and content. For further information, please contact the cited source.
A team of researchers has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.READ MORE
2nd AI Pharma Innovation: Drug Discovery 2019 Summit
Feb 27 - Feb 28, 2019
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
14th World Congress on Medicinal Chemistry and Drug Design
Jun 10 - Jun 11, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019